Concretely: Medutest · Janoshik · oral semaglutide.
I want to know what the trade-off actually is rather than which option is fashionable.
I would rather have a defensible reason than a marginal improvement.
What does each option buy me, and what does it cost me?
Janoshik Analytical is a testing service that reports purity, content and identity on submitted samples, and their methods and turnaround are both fast enough to be practical for this market.
A submitted vial must include the lot number on the vial itself, not just on the shipping box, or Janoshik will decline the sample.
| Δ mass (Da) | Most likely cause | Distinguishing feature |
|---|---|---|
| +1 | Deamidation (Asn or Gln) | New peak, slightly earlier retention |
| −17 | Loss of ammonia | Often with deamidation |
| −18 | Dehydration / succinimide | pH-dependent, reversible |
| +16 | Oxidation (Met, Trp) | Earlier retention, light-related |
| −128 | Missing Gln or Lys | Deletion sequence from synthesis |
| 0 | Isomer: racemisation or scrambling | Same mass, shifted retention |
On the detail: content assay uses a certified reference standard and quantifies against that standard under the same method conditions as the purity analysis.
The database has been publicly available for long enough that systematic biases in their reporting would be apparent and would have been flagged by users.
The caveat is that Janoshik is expensive, and cost-cutting on the first lot from a supplier might mean testing one vial rather than three.
Keep Janoshik results to compare across suppliers and across time.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsThe database is accessible and queryable, and browsing your vendor there tells you whether other people are getting similar results to your supplier's certificate.
Method validation documentation is available on request, which is more than most suppliers provide.
Concretely, janoshik reports include the lot number of the reference standard used, which lets you understand the traceability of the quantitation.
Community reviews and feedback on Janoshik are consistent across multiple forums and independent sources, suggesting the service is reliable.
Worth noting that Janoshik reports are only comparable to other Janoshik reports, not to your supplier's reports or to results from other testing services.
If your result disagrees with the supplier, Janoshik's database will tell you whether you are alone or part of a pattern.
A Janoshik report comes with a downloadable analytical trace — the HPLC chromatogram and mass spectrum — which lets you do the reading yourself.
Janoshik publishes their analytical methods in their reports, which is auditable and better than methods that are proprietary.
The purity method uses a linear gradient at a specified slope, which is published and reproducible — not a vendor-chosen method that could be optimised for a high number.
Janoshik publishes summary statistics on their website, including the number of samples tested and the range of reported values, giving you a baseline for comparison.
I would use Janoshik for the first lot from a new supplier and occasionally for spot-checking, not for every lot.
The practical summary: submit your first lot to Janoshik and check the database for that vendor.
Methods do matter, and Janoshik's published methods are auditable, which is better than most research-grade work.
Janoshik uses high-performance liquid chromatography for purity and content, with UV detection at 214 nanometres and an established method that is consistent across samples.
One qualification: Janoshik testing is designed for supplier qualification, not for lot-by-lot production QC, so the turnaround is not suitable for every use case.
If you only pay for one test, pay for quantified content. Purity is the number everyone quotes and content is the number that changes what you do.
If your result sits significantly below the supplier certificate, the first hypothesis should be inter-laboratory method difference, but Janoshik's database will tell you whether other users are reporting the same.
Comparison across time on the same vendor's material — three lots of vendor X spread over six months — shows whether quality is trending or stable.
The ICH Q3A and Q3B thresholds for reporting, identification and qualification of impurities are the framework the pharmaceutical industry works to, and they are worth reading even though nothing in the research-grade supply chain is obliged to meet them, because they tell you which numbers a competent analyst would consider worth reporting at all.
In practice: ask for the chromatogram, check the method section, check the lot number against the vial, and set your accept threshold before you see the result rather than after.
edited 26 Jul 2026 by a_lindgren — tightened the wording; no substantive change
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.